According to the data, five cancer types with high ITGAL expression predicted good prognosis (TCGA-CESC [N=273, p<0.05], TCGA-LUAD [N=490, p<0.05], TCGA-SARC [N=254, p<0.05], TCGA-HNSC [N=509, p<0.05], and TCGA-SKCM [N=444, p<0.05]), while two cancer types with high ITGAL expression predicted poor prognosis (TCGA-LGG [N=504, p<0.05] and TCGA-GBM [N=152, p<0.05]) (Figure 6). This evidence concerns the gene ITGAL and glioblastoma.